{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Safety+Control&page=80", "query": { "intervention": "Safety Control", "page": 80 }, "page_size": 10 }, "pagination": { "page": 80, "page_size": 10, "total_count": 14141, "total_pages": 1415, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Safety+Control&page=81&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Safety+Control&page=79&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-09T03:27:45.184Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03840993", "title": "Safety and Efficacy Study of MT-2990 in Women With Endometriosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Endometrial Related Pain" ], "interventions": [ { "name": "MT-2990", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tanabe Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "FEMALE", "summary": "18 Years to 49 Years · Female only" }, "enrollment_count": 76, "start_date": "2019-01-15", "completion_date": "2021-10-05", "has_results": true, "last_update_posted_date": "2025-12-31", "last_synced_at": "2026-11-09T03:27:45.184Z", "location_count": 51, "location_summary": "Phoenix, Arizona • Sacramento, California • San Diego, California + 39 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03840993" }, { "nct_id": "NCT04101721", "title": "Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Retinopathy of Prematurity" ], "interventions": [ { "name": "aflibercept", "type": "DRUG" }, { "name": "laser photocoagulation", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 127, "start_date": "2019-10-30", "completion_date": "2022-08-18", "has_results": true, "last_update_posted_date": "2023-07-20", "last_synced_at": "2026-11-09T03:27:45.184Z", "location_count": 27, "location_summary": "Phoenix, Arizona • La Jolla, California • Loma Linda, California + 21 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04101721" }, { "nct_id": "NCT02870322", "title": "Fruit And Vegetable Or Recreation Prescriptions for UW-Madison Students", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Overweight", "Obesity" ], "interventions": [ { "name": "Fruit and Vegetable CSA Prescription", "type": "BEHAVIORAL" }, { "name": "Bikeshare Prescription", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "24 Years", "sex": "ALL", "summary": "18 Years to 24 Years" }, "enrollment_count": 25, "start_date": "2016-07", "completion_date": "2017-10-24", "has_results": false, "last_update_posted_date": "2017-10-26", "last_synced_at": "2026-11-09T03:27:45.184Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02870322" }, { "nct_id": "NCT00002253", "title": "A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either \"Responders\" or \"Non-Responders\" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diarrhea", "HIV Infections" ], "interventions": [ { "name": "Octreotide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sandoz", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-11-09T03:27:45.184Z", "location_count": 22, "location_summary": "Los Angeles, California • San Diego, California • San Francisco, California + 17 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Mateo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002253" }, { "nct_id": "NCT00123253", "title": "TH9507 in Patients With HIV-Associated Lipodystrophy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV Infections", "Lipodystrophy" ], "interventions": [ { "name": "TH9507", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Theratechnologies", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 412, "start_date": "2005-06", "completion_date": "2007-04", "has_results": false, "last_update_posted_date": "2013-11-27", "last_synced_at": "2026-11-09T03:27:45.184Z", "location_count": 35, "location_summary": "Los Angeles, California • Palm Springs, California • San Diego, California + 25 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palm Springs", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "West Hollywood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00123253" }, { "nct_id": "NCT02802228", "title": "Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Portal Hypertension", "Liver Cirrhosis" ], "interventions": [ { "name": "Ifetroban", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cumberland Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 30, "start_date": "2017-03-06", "completion_date": "2018-07-17", "has_results": true, "last_update_posted_date": "2022-01-19", "last_synced_at": "2026-11-09T03:27:45.184Z", "location_count": 6, "location_summary": "Tampa, Florida • Indianapolis, Indiana • Columbus, Ohio + 3 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02802228" }, { "nct_id": "NCT06872892", "title": "The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bronchiectasis" ], "interventions": [ { "name": "BI 1291583", "type": "DRUG" }, { "name": "Placebo matching BI 1291583", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1755, "start_date": "2025-06-09", "completion_date": "2027-12-20", "has_results": false, "last_update_posted_date": "2026-10-28", "last_synced_at": "2026-11-09T03:27:45.184Z", "location_count": 78, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 67 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Redding", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06872892" }, { "nct_id": "NCT02682511", "title": "Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Scleroderma, Diffuse", "Scleroderma, Systemic", "Scleroderma, Limited", "Sclerosis, Progressive Systemic", "Skin Diseases", "Connective Tissue Diseases", "Pathologic Processes", "Autoimmune Diseases" ], "interventions": [ { "name": "Oral Ifetroban", "type": "DRUG" }, { "name": "Oral Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cumberland Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 34, "start_date": "2017-01", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-11-09T03:27:45.184Z", "location_count": 10, "location_summary": "Tucson, Arizona • Los Angeles, California • Weston, Florida + 7 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Weston", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02682511" }, { "nct_id": "NCT00818311", "title": "Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Radiation Tolerance", "Skin Aging", "Rhytids" ], "interventions": [ { "name": "LED GentleWaves®", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "L'Oreal", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2008-06", "completion_date": "2008-12", "has_results": false, "last_update_posted_date": "2009-01-07", "last_synced_at": "2026-11-09T03:27:45.184Z", "location_count": 1, "location_summary": "Carrollton, Texas", "locations": [ { "city": "Carrollton", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00818311" }, { "nct_id": "NCT00796744", "title": "Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Foot Ulcer, Diabetic", "Diabetic Foot" ], "interventions": [ { "name": "NorLeu3-A(1-7) in a gel formulation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "US Biotest, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 78, "start_date": "2008-10", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2012-09-27", "last_synced_at": "2026-11-09T03:27:45.184Z", "location_count": 12, "location_summary": "Tucson, Arizona • Castro Valley, California • San Diego, California + 8 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Castro Valley", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Sylmar", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00796744" } ] }